Adoptive cell therapy (ACT) involves the extraction of precursor cells from autologous or allogeneic anti-tumor effector cells, followed by their in vitro induction, activation, and expansion using activators such as IL-2 and specific peptides. Here, IL2 is linked to neoplasm.